Cargando…
Does the Angiotensin-converting enzyme (ACE) gene insertion/deletion polymorphism modify the response to ACE inhibitor therapy? – A systematic review
BACKGROUND: Pharmacogenetic testing to individualize ACE inhibitor therapy remains controversial. We conducted a systematic review to assess the effect modification of the insertion/deletion (I/D) polymorphism of the ACE gene on any outcome in patients treated with ACE inhibitors for cardiovascular...
Autores principales: | Scharplatz, Madlaina, Puhan, Milo A, Steurer, Johann, Perna, Annalisa, Bachmann, Lucas M |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1283147/ https://www.ncbi.nlm.nih.gov/pubmed/16242049 http://dx.doi.org/10.1186/1468-6708-6-16 |
Ejemplares similares
-
What is the impact of the ACE gene insertion/deletion (I/D) polymorphism on the clinical effectiveness and adverse events of ACE inhibitors? – Protocol of a systematic review
por: Scharplatz, M, et al.
Publicado: (2004) -
The Insertion/Deletion Polymorphism of the Angiotensin Converting Enzyme (ACE) in Parkinson’s Disease
por: Papapetropoulos, Spiridon, et al.
Publicado: (2008) -
Angiotensin-Converting Enzyme (ACE) Gene Insertion/Deletion Polymorphism and ACE Inhibitor-Related Cough: A Meta-Analysis
por: Li, Ya-Feng, et al.
Publicado: (2012) -
Angiotensin-converting enzyme (ACE) insertion/deletion polymorphism and circulating ACE levels are not associated with outcome in septic critically ill patients
por: Tsangaris, I, et al.
Publicado: (2011) -
Analysis of the insertion/deletion polymorphism of the human angiotensin converting enzyme (ACE) gene in patients with renal cancer
por: Usmani, B A, et al.
Publicado: (2000)